Rosacea is associated with chronic systemic diseases in a skin severity–dependent manner: Results of a case-control study

Published:August 06, 2015DOI:


      Rosacea is a common chronic inflammatory dermatosis of unclear origin. It has been associated with systemic comorbidities, but methodical studies addressing this association are lacking.


      We evaluated: (1) the association between rosacea and systemic comorbidities; and (2) if the severity of rosacea is impacted by comorbidities.


      This was a case-control study: patients with rosacea were matched (1:1) to rosacea-free control subjects by age, sex, and race. Relative risk estimates were calculated using logistic regression as odds ratios with 95% confidence intervals.


      Among 130 participants (65 patients/65 control subjects), we observed a significant association between rosacea and allergies (airborne, food), respiratory diseases, gastroesophageal reflux disease, other gastrointestinal diseases, hypertension, metabolic and urogenital diseases, and female hormone imbalance. Compared with mild rosacea, moderate to severe rosacea was significantly associated with hyperlipidemia, hypertension, metabolic diseases, cardiovascular diseases, and gastroesophageal reflux disease.


      This was a case-control study with moderate sample size. Associated medical conditions were self-reported and could not always be confirmed by medication use and medical records.


      Rosacea is associated with numerous systemic comorbid diseases in a skin severity–dependent manner. Physicians should be aware of these associations to provide comprehensive care to patients with rosacea, especially to those with more severe disease.

      Key words

      Abbreviations used:

      CI (confidence interval), CVD (cardiovascular disease), GERD (gastroesophageal reflux disease), GI (gastrointestinal), OR (odds ratio)
      To read this article in full you will need to make a payment
      AAD Member Login
      AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Spoendlin J.
        • Voegel J.J.
        • Jick S.S.
        • et al.
        A study on the epidemiology of rosacea in the U.K.
        Br J Dermatol. 2012; 167: 598-605
        • Watson W.C.
        • Paton E.
        • Murray D.
        Small-bowel disease in rosacea.
        Lancet. 1965; 1: 47-50
        • Walton S.
        • Sheth M.
        • Wyatt E.H.
        Rosacea and ulcerative colitis: a possible association.
        J Clin Gastroenterol. 1990; 12: 513-515
        • Romiti R.
        • Jansen T.
        • Heldwein W.
        • et al.
        Rosacea fulminans in a patient with Crohn's disease: a case report and review of the literature.
        Acta Derm Venereol. 2000; 80: 127-129
        • Kendall S.N.
        Remission of rosacea induced by reduction of gut transit time.
        Clin Exp Dermatol. 2004; 29: 297-299
        • Parodi A.
        • Paolino S.
        • Greco A.
        • et al.
        Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication.
        Clin Gastroenterol Hepatol. 2008; 6: 759-764
        • Gravina A.
        • Federico A.
        • Ruocco E.
        • et al.
        Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea.
        United European Gastroenterol J. 2015; 3: 17-24
        • Jones M.P.
        • Knable Jr., A.L.
        • White M.J.
        • et al.
        Helicobacter pylori in rosacea: lack of an association.
        Arch Dermatol. 1998; 134: 511
        • Duman N.
        • Ersoy Evans S.
        • Atakan N.
        Rosacea and cardiovascular risk factors: a case control study.
        J Eur Acad Dermatol Venereol. 2014; 28: 1165-1169
        • Gupta M.A.
        • Gupta A.K.
        • Chen S.J.
        • et al.
        Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey–outpatient department data collected by the U.S. National Center for Health Statistics from 1995 to 2002.
        Br J Dermatol. 2005; 153: 1176-1181
        • Spoendlin J.
        • Bichsel F.
        • Voegel J.J.
        • et al.
        The association between psychiatric diseases, psychotropic drugs and the risk of incident rosacea.
        Br J Dermatol. 2014; 170: 878-883
        • Spoendlin J.
        • Voegel J.J.
        • Jick S.S.
        • et al.
        Migraine, triptans, and the risk of developing rosacea: a population-based study within the United Kingdom.
        J Am Acad Dermatol. 2013; 69: 399-406
        • Wilkin J.
        • Dahl M.
        • Detmar M.
        • et al.
        Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea.
        J Am Acad Dermatol. 2004; 50: 907-912
        • Klipin M.
        • Mare I.
        • Hazelhurst S.
        • et al.
        The process of installing REDCap, a web-based database supporting biomedical research: the first year.
        Applied Clin Inform. 2014; 5: 916-929